|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
NovaBay Pharmaceuticals, Inc.
| | | Phone: | (510) 899-8800 | Fax: | (510) 225-0371 | Year Established: | 2000 | Employees: | 35 | Ticker: | NBY | Exchange: | NYSE | Main Contact: | Glenn Moro, VP, Sales & Marketing | | Other Contacts: | Mark Sieczkarek, M.B.A., CEO Thomas Paulson, M.B.A., CFO Justin Hall, Esq, Senior VP & & General Counsel Greg Miller, Director, Strategic Sales
| | Company Description | NovaBay Pharmaceuticals (formerly NovaCal Pharmaceuticals) is a biopharmaceutical company focusing on the commercialization of prescription Avenova® lid and lash hygiene for the eye care market. Avenova is formulated with Neutrox®, which is cleared by the U.S. Food and Drug Administration (FDA) as a 510(k) medical device. Neutrox is NovaBay’s pure hypochlorous acid. Data from a multicenter clinical study show that Avenova reduced bacterial load, the underlying cause of blepharitis, on ocular skin surface by more than 90%. Laboratory tests show that hypochlorous acid has potent antimicrobial activity in solution yet is non-toxic to mammalian cells and also neutralizes bacterial toxins. Avenova is marketed to optometrists and ophthalmologists throughout the U.S. by NovaBay’s direct medical salesforce. It is accessible from more than 90% of retail pharmacies in the U.S. through agreements with McKesson Corporation, Cardinal Health and AmeriSource Bergen. | |
|
|
|
|
|